xxb750
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 29, 2020 (NCT06558097)
Timeline
Indications
Mechanism of action
NPR1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06142383 | Phase 2 | Dec 14, 2023 | Novartis |
| NCT05562934 | Phase 2 | Nov 8, 2022 | Novartis |
| NCT05328752 | Phase 1 | May 17, 2022 | Novartis |
| NCT06558097 | Phase 1 | Jul 29, 2020 | Novartis |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 4 | 4 | 2 | 2020 |
1 organizations
Page 1 / 1